Literature DB >> 3514470

[Effect of pH value and magnesium on the antibacterial activity of quinolone preparations].

J T Smith, N T Ratcliffe.   

Abstract

The activity of ten different 4-quinolone antibacterial agents against Escherichia coli KL16 was investigated at four pH values between 5.6 and 8.3, which is the pH range of urine. It was found that pH affected the minimum inhibitory concentrations of all the drugs, but the nature of the substituent at the C7 position of each 4-quinolone governed how its activity was altered by the hydrogen ion concentration. When a 4-quinolone possessed a piperazine group at its C7 position its activity became progressively less as the pH fell. However, all drugs that lacked a C7 piperazine, irrespective of the nature of their substituent at this position, exhibited a progressive increase in activity as the pH was reduced. In addition it was found that, excepting cinoxacin, a urinary concentration of magnesium generally caused a further antagonism of the activity of the nine other 4-quinolone antibacterials at all pH values tested.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3514470     DOI: 10.1007/bf01645195

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  6 in total

1.  Mutational resistance to 4-quinolone antibacterial agents.

Authors:  J T Smith
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

2.  Influence of urinary pH on the pharmacokinetics of cinoxacin in humans and on antibacterial activity in vitro.

Authors:  R H Barbhaiya; A U Gerber; W A Craig; P G Welling
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

3.  Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.

Authors:  N X Chin; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

4.  Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.

Authors:  M W Hane; T H Wood
Journal:  J Bacteriol       Date:  1969-07       Impact factor: 3.490

5.  Bactericidal effects of norfloxacin towards bacteria in urine.

Authors:  R W Lacey; V L Lord; G L Howson
Journal:  J Antimicrob Chemother       Date:  1984-05       Impact factor: 5.790

6.  Researches on antibacterial and antifungal agents. I. Analogs of nalidixic acid with a pyrrole moiety.

Authors:  F Corelli; S Massa; G Stefancich; M Artico; S Panico; N Simonetti
Journal:  Farmaco Sci       Date:  1983-04
  6 in total
  8 in total

Review 1.  Quinolone antimicrobial agents: adverse effects and bacterial resistance.

Authors:  J S Wolfson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

2.  Hyperosmotic Agents and Antibiotics Affect Dissolved Oxygen and pH Concentration Gradients in Staphylococcus aureus Biofilms.

Authors:  Mia Mae Kiamco; Erhan Atci; Abdelrhman Mohamed; Douglas R Call; Haluk Beyenal
Journal:  Appl Environ Microbiol       Date:  2017-03-02       Impact factor: 4.792

Review 3.  Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples.

Authors:  H Nikaido; D G Thanassi
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

4.  Influences of urinary pH on ciprofloxacin pharmacokinetics in humans and antimicrobial activity in vitro versus those of sparfloxacin.

Authors:  M Kamberi; K Tsutsumi; T Kotegawa; K Kawano; K Nakamura; Y Niki; S Nakano
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

Review 5.  Clinical pharmacokinetics of the newer antibacterial 4-quinolones.

Authors:  M Neuman
Journal:  Clin Pharmacokinet       Date:  1988-02       Impact factor: 6.447

Review 6.  Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Monk; D M Campoli-Richards
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

7.  In vitro and in vivo antibacterial activities of BMY 40062, a new fluoronaphthyridone.

Authors:  J Fung-Tomc; J V Desiderio; Y H Tsai; G Warr; R E Kessler
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

8.  Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation.

Authors:  D C Hooper; J S Wolfson; K S Souza; E Y Ng; G L McHugh; M N Swartz
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.